anti-CD3/anti-HER3 bispecific T-cell engager Y-Body (Wuhan YZY Biopharma)

N/A

Report date: 2026/03/19 16:58:23

Base Information

Drug Nameanti-CD3/anti-HER3 bispecific T-cell engager Y-Body (Wuhan YZY Biopharma)
Drug Alias Nameanti-HER3/anti-CD3 bispecific antibody Y-Body (Wuhan YZY Biopharma)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers
Mechanisms of ActionReceptor tyrosine-protein kinase erbB-3 modulatorsT cell surface glycoprotein CD3 modulators
TargetsT cell surface glycoprotein CD3Receptor tyrosine-protein kinase erbB-3
Therapy Area/IndicationsStomach NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesWuhan Yzy Biopharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWuhan Yzy Biopharma Co Ltd
Active IndicationsN/A
Inactive IndicationsStomach NeoplasmsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A